Literature DB >> 24333314

Clinical use of factor VIII and factor IX concentrates.

Massimo Morfini1, Antonio Coppola2, Massimo Franchini3, Giovanni Di Minno2.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333314      PMCID： PMC3853992          DOI： 10.2450/2013.010s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  67 in total

1.  Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

Authors:  G C White; F Rosendaal; L M Aledort; J M Lusher; C Rothschild; J Ingerslev
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

Review 2.  Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.

Authors:  Javier Batlle; Ana Villar; Antonio Liras; Concepción Alonso; Carmen Altisent; Dilia Brito; Manuel Moreno; Félix Lucía; Carmen Sedano; Manuel Prieto; Natividad Calvente; José A Aznar; Víctor Jiménez; Vicente Soriano; Javier R Martorell; Gemma Iruín; Juan M Bergua; Carlos Aguilar
Journal:  Blood Coagul Fibrinolysis       Date:  2008-07       Impact factor: 1.276

3.  Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia.

Authors:  G C White; C W McMillan; H S Kingdon; C B Shoemaker
Journal:  N Engl J Med       Date:  1989-01-19       Impact factor: 91.245

Review 4.  Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.

Authors:  Antonio Coppola; Matteo N D Di Minno; Elena Santagostino
Journal:  Br J Haematol       Date:  2010-06-22       Impact factor: 6.998

5.  Mortality and causes of death in Italian persons with haemophilia, 1990-2007.

Authors:  A Tagliaferri; G F Rivolta; A Iorio; E Oliovecchio; M E Mancuso; M Morfini; A Rocino; M G Mazzucconi; M Franchini; N Ciavarella; A Scaraggi; L Valdrè; G Tagariello; P Radossi; G Muleo; P G Iannaccaro; C Biasoli; D Vincenzi; M L Serino; S Linari; C Molinari; E Boeri; M La Pecorella; M T Carloni; E Santagostino; G Di Minno; A Coppola; A Rocino; E Zanon; L Spiezia; C Di Perna; M Marchesini; M Marcucci; A Dragani; S Macchi; P Albertini; M D'Incà; C Santoro; F Biondo; G Piseddu; G Rossetti; G Barillari; G Gandini; A C Giuffrida; G Castaman
Journal:  Haemophilia       Date:  2010-02-09       Impact factor: 4.287

6.  VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.

Authors:  Suryasarathi Dasgupta; Yohann Repessé; Jagadeesh Bayry; Ana-Maria Navarrete; Bharath Wootla; Sandrine Delignat; Theano Irinopoulou; Caroline Kamaté; Jean-Marie Saint-Remy; Marc Jacquemin; Peter J Lenting; Annie Borel-Derlon; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

7.  Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia.

Authors:  Flora Peyvandi; Manijeh Lak; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2002-05       Impact factor: 9.941

8.  Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper.

Authors:  A B Colowick; R L Bohn; J Avorn; B M Ewenstein
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

9.  International workshop on immune tolerance induction: consensus recommendations.

Authors:  D M DiMichele; W K Hoots; S W Pipe; G E Rivard; E Santagostino
Journal:  Haemophilia       Date:  2007-07       Impact factor: 4.287

10.  A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group.

Authors:  L M Aledort; R H Haschmeyer; H Pettersson
Journal:  J Intern Med       Date:  1994-10       Impact factor: 8.989
View more
  8 in total

1.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

2.  Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.

Authors:  Muhammad Tariq Masood Khan; Arshi Naz; Jawad Ahmed; Tahir Shamsi; Shariq Ahmed; Nisar Ahmed; Ayisha Imran; Nazish Farooq; Muhammad Tariq Hamayun Khan; Abid Sohail Taj
Journal:  Clin Appl Thromb Hemost       Date:  2017-07-28       Impact factor: 2.389

3.  Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.

Authors:  Gabriele Calizzani; Ivana Menichini; Fabio Candura; Monica Lanzoni; Samantha Profili; Maria Rita Tamburrini; Antonio Fortino; Stefania Vaglio; Giuseppe Marano; Giuseppina Facco; Emily Oliovecchio; Massimo Franchini; Antonio Coppola; Romano Arcieri; Cinzia Bon; Mario Saia; Sabina Nuti; Massimo Morfini; Giancarlo M Liumbruno; Giovanni Di Minno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

4.  Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection.

Authors:  Gerard Solís-Díez; Marta Turu-Pedrola; Marta Roig-Izquierdo; Corinne Zara; Antoni Vallano; Caridad Pontes
Journal:  Front Public Health       Date:  2022-05-19

5.  In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients.

Authors:  T Preijers; M W F van Spengler; K Meijer; K Fijnvandraat; K Fischer; F W G Leebeek; M H Cnossen; R A A Mathôt
Journal:  Eur J Clin Pharmacol       Date:  2021-10-15       Impact factor: 2.953

Review 6.  Pain in Hemophilia: Unexplored Role of Oxidative Stress.

Authors:  Raghda Fouda; Donovan A Argueta; Kalpna Gupta
Journal:  Antioxidants (Basel)       Date:  2022-06-03

Review 7.  Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities-a practical review.

Authors:  Cedric Hermans; Gerry Dolan
Journal:  Ther Adv Hematol       Date:  2020-10-20

Review 8.  Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia.

Authors:  Tim Preijers; Lisette M Schütte; Marieke J H A Kruip; Marjon H Cnossen; Frank W G Leebeek; Reinier M van Hest; Ron A A Mathôt
Journal:  Clin Pharmacokinet       Date:  2021-01       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.